Drug Discovery and Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE

Study: Vaccines Should Be Given Through the Mucosa

By University of Gothenburg | September 16, 2016

The mucosa forms special immunological memory – a breakthrough for vaccine research.

If a vaccine is to protect the intestines and other mucous membranes in the body, it also needs to be given through the mucosa, for example as a nasal spray or a liquid that is drunk. The mucosa forms a unique immunological antibody memory that does not occur if the vaccine is given by injection. This has been shown by a new study from Sahlgrenska Academy published in Nature Communications.

Immunological memory is the secret to human protection against various diseases and the success of vaccines. It allows our immune system to quickly recognize and neutralize threats. “The largest part of the immune system is in our mucosa. Even so, we understand less about how immunological memory protects us there than we do about protection in the rest of the body. Some have even suggested that a typical immune memory function does not exist in the mucosa,” says Mats Bemark, associate professor of immunology at Sahlgrenska Academy, University of Gothenburg.

After extensive work, the research team at Sahlgrenska Academy can now show that this assumption is completely wrong.

Lifelong Intestine Memory

In studies in mice, the researchers show that the mucosal immune system can lead to a lifelong memory in the intestines of mice. After immunization, long-lived cells make antibodies that are transported into the intestine through the mucosa. In addition, memory cells form that can rapidly initiate a new immune response if needed and that can form new cells that produce antibodies.

“We show that the memory cells created in the mucosa are different from memory cells formed in other parts of the body. And a bit surprisingly, it seems that the cells that make antibodies in the mucosa and the memory cells in the mucosa are not created at the same time,” says Bemark.

Unique Memory Cells

The researchers’ findings have major implications for future vaccine development.
“The study clearly shows that it is possible to achieve an immunological antibody memory with mucosal vaccination and that the memory cells that are created in connection with this type of vaccination are unique and cannot be achieved through traditional vaccination methods. This means that only mucosal vaccinations can provide immunological protection in the mucosa,” says Nils Lycke, professor of clinical immunology at Sahlgrenska Academy.

For the study, the research team used a new method in which mice were immunized with a model vaccine (called an antigen) that is given orally. The researchers could then follow the cells formed during the immune response for the rest of the mouse’s life.

“Because we have focused on how this provides protection over the long-term, each experiment lasted between six months and two years. This work is unique because this new methodology allows us to follow these very rare memory cells with very good resolution, and that we can follow the response for such a long time,” says Bemark.

To read the full press release, click here.

Follow us on Twitter and Facebook for updates on the latest pharmaceutical and biopharmaceutical manufacturing news! 


Filed Under: Drug Discovery

 

Related Articles Read More >

EVEREST lead investigator on why Dupixent sets a new bar for treating coexisting CRSwNP and asthma
Sanders, King target DTC pharma ads but the industry worries more about threats to its $2B R&D model
Zoliflodacin wins FDA nod for treatment of gonorrhea
FDA approved ENFLONSIA for the prevention of RSV in Infants
“ddd
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest news and trends happening now in the drug discovery and development industry.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
Drug Discovery and Development
  • MassDevice
  • DeviceTalks
  • Medtech100 Index
  • Medical Design Sourcing
  • Medical Design & Outsourcing
  • Medical Tubing + Extrusion
  • Subscribe to our E-Newsletter
  • Contact Us
  • About Us
  • R&D World
  • Drug Delivery Business News
  • Pharmaceutical Processing World

Copyright © 2025 WTWH Media LLC. All Rights Reserved. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media
Privacy Policy | Advertising | About Us

Search Drug Discovery & Development

  • Home Drug Discovery and Development
  • Drug Discovery
  • Women in Pharma and Biotech
  • Oncology
  • Neurological Disease
  • Infectious Disease
  • Resources
    • Video features
    • Podcast
    • Voices
    • Webinars
  • Pharma 50
    • 2025 Pharma 50
    • 2024 Pharma 50
    • 2023 Pharma 50
    • 2022 Pharma 50
    • 2021 Pharma 50
  • Advertise
  • SUBSCRIBE